The potential advantages of infrared spectroscopic imaging for examination of cells and tissue biopsies for cancer histopathology is high, however there are fundamental limitations of FTIR that must first be addressed. One limitation is that Infrared spectroscopy lacks the sensitivity to detect biomarkers of disease directly. With cancer being one of the leading causes of death and its increasing prevalence, it is important to develop tools that can rapidly screen and enable rapid and simultaneous fingerprinting of biologic content and metabolic state. To address these limitations, probed Infrared spectroscopy is being explored. We report the successful synthesis, characterization, and application of metal carbonyl loaded nanoparticle probes for the detection of breast cancer biomarkers.
|